T,RNA PVT1

Hirotaka Kato1,2, Tomohide Tsukahara3, Kenji Murata1

  • 1Department of Pathology, School of Medicine, Sapporo Medical University, South-1, West-17, Chuo-Ku, Sapporo, Hokkaido, 060-8556, Japan.

概括

一种针对固体瘤的新型免疫疗法使用单链可变片段 (scFv) 针对HLA-A24/HF10复合体被开发出来. 这种HF10xCD3双特异性抗体在临床前模型中表现出显著的抗瘤活性.